Dusseldorf, Germany
DNTOX is a biotechnology startup established in 2022 with a focus on developing safe chemicals for healthy brain development without animal experiments. The company's slogan, "Safe chemicals for a healthy brain development without animal experiments," embodies its mission. DNTOX is dedicated to building a bioanalytical testing laboratory for animal-free screening of chemicals to assess their potential impact on brain development and developmental neurotoxicity (DNT).
The startup's in vitro testing battery is designed around human cell models, allowing for high-content and medium-throughput chemical screening. DNTOX also employs an in-house developed software powered by artificial intelligence to support its testing processes. The company aims to assist its clients in identifying safe lead structures during substance development and in the safety assessment for chemical approval and re-approval processes.
DNTOX, with its innovative approach, seeks to actualize its vision of achieving safe chemicals without animal experiments. The company's headquarters is located in Germany. In its latest funding round on 14 June 2023, DNTOX secured a €1.40M investment from notable investors including AQAL Group, Nikolaus Sturm, Bool Capital, and HTGF | High-Tech Gruenderfonds, along with individual investor Barbara Korte-Sturm.
DNTOX operates within the Biotechnology and Life Sciences industries, positioning itself at the intersection of technological innovation and ethical, sustainable practices. With its recent investment, DNTOX is poised to advance its mission of revolutionizing chemical testing and safety assessment in a manner that aligns with contemporary ethical and environmental standards.
